Combination therapy with lorlatinib and mitogen-activated protein kinase pathway inhibition in previously treated ALK- or ROS1-rearranged lung cancer

Lung Cancer 2026

View at publisher
Authors: Jaime Laurel Schneider, Alona Muzikansky, Elizabeth Krueger, Justin F. Gainor, Jessica J. Lin, Susan Symes, Alice Tsang Shaw, Ibiayi Dagogo-Jack
DOI: 10.1016/j.lungcan.2026.108945
Cited by: 1
References: 36

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Melanoma and MAPK Pathways Lung Cancer Diagnosis and Treatment

Publication details

Journal / source
Lung Cancer
Publisher
Elsevier BV
Volume
213
Pages
108945–108945
Publication date
27 January 2026
Language
EN